Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BvfiledCriticalSynthon Bv
Priority to ARP070103129priorityCriticalpatent/AR062062A1/en
Publication of AR062062A1publicationCriticalpatent/AR062062A1/en
Se refiere a una sal de amantadina de montelucast, a un proceso para preparar una sal de amantadina de montelucast, a una composicion farmacéutica que comprende esta sal y a un proceso para purificar montelucast o sus sales. Reivindicacion 2: Una sal de montelicast, caracterizada porque tiene la formula (1).It refers to a montelucast amantadine salt, a process to prepare a montelucast amantadine salt, a pharmaceutical composition comprising this salt and a process to purify montelucast or its salts. Claim 2: A montelicast salt, characterized in that it has the formula (1).
ARP0701031292007-07-132007-07-13
MONTELUCAST AMANTADINE SALT
AR062062A1
(en)
COMPOUNDS DERIVED FROM ADENINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS, USEFUL TO TREAT ALLERGIC, VIRAL OR CANCER DISEASES, AMONG OTHERS.